Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice (Q45306447)

11 December 2017

Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice (English)

1 reference

11 December 2017

0 references

1 reference

3

1 reference

11 December 2017

Michael A Johnson

1

0 references

author name string

Melissa Villanueva

2

1 reference

11 December 2017

Andrew T Seipel

4

1 reference

11 December 2017

Leah A Buhler

5

1 reference

11 December 2017

R Mark Wightman

6

1 reference

11 December 2017

language of work or name

English

0 references

publication date

14 September 2007

1 reference

Journal of Neurochemistry

11 December 2017

1 reference

11 December 2017

103

1 reference

11 December 2017

5

1 reference

11 December 2017

2102-2110

1 reference

Striatal neurochemical changes in transgenic models of Huntington's disease

11 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Regional mitochondrial respiratory activity in Huntington's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Structure and function of the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

ATP Deficits and Neuronal Degeneration Induced by 3-Nitropropionic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

The SNARE protein SNAP-25 is linked to fast calcium triggering of exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Regulation of quantal size by presynaptic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

The chromaffin cell and its development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Mitochondria and dystonia: the movement disorder connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04908.X

10.1111/J.1471-4159.2007.04908.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference